Vilanterol vs formoterol in obstructive airway diseases: A comprehensive review of efficacy, safety, and clinical advantages in light of Global Initiative for Asthma 2024 and Global Initiative for Chronic Obstructive Lung Disease 2024 guidelines
Volume 61 | Issue 1 | January-March 2025
We value your privacy
We use necessary cookies to run this website. With your consent, we may also use analytics, preference, functional, and marketing cookies.